All Stories

  1. Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism

    Article • Clinical Journal of the American Society of Nephrology, September 2023, Wolters Kluwer Health

    Tadao Akizawa

  2. Authors’ Reply

    Article • Journal of the American Society of Nephrology, March 2021, American Society of Nephrology

    Tadao Akizawa

  3. Authors’ Reply

    Article • Journal of the American Society of Nephrology, September 2020, American Society of Nephrology

    Tadao Akizawa

  4. Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

    Article • Journal of the American Society of Nephrology, June 2020, American Society of Nephrology

    Tadao Akizawa

  5. Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan

    Article • Clinical Pharmacology Advances and Applications, September 2018, Dove Medical Press

    Masafumi Fukagawa, Tadao Akizawa

  6. Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study

    Article • Therapeutic Apheresis, June 2014, Wiley

    Tadao Akizawa